A team from the Human Protein Atlas is attending the AACR Annual Meeting 2017 in Washington DC right now. This year, the meeting covers topics on research propelling cancer prevention and cures. The Human Protein Atlas is represented by a booth where researchers give a personalized tutorial of the portal to interested visitors. In addition, a demo version of a new Pathology Atlas containing information on prognostic genes and proteins associated with clinical outcome. The Pathology Atlas focuses on 17 major cancer types in humans.

"Cancer is one of the leading causes of death worldwide and there is great interest in understanding the underlying molecular mechanisms involved in the pathogenesis and progression of individual tumors," Mathias Uhlen, director of the Human Protein Atlas says. "The Pathology Atlas provides researchers the possibility to explore the effect of individual genes and the consequences of high and low expression for the survival of a given cancer patient."

In addition to the preview in our booth, Mathias Uhlen, as an invited speaker at the conference, will give a talk: "A human pathology atlas: Expression profiles related to clinical outcome of cancers".

The AACR Annual Meeting highlights the latest achievements in cancer research and medicine from institutions all over the world. Apart from staffing our booth, our team is also attending sessions at the meeting, covering topics from cancer chemistry to immunotherapy, clinical trials, endocrinology, epidemiology, and experimental and molecular therapeutics.

Professor Fredrik Pontén is director of our Cancer Atlas, and one of the attendees at the AACR-meeting.

"This is such a big and important meeting, and I am so glad the Human Protein Atlas is here to participate", he says. "During my hours in our booth I have met with many important cancer researchers, and it has been a pleasure to be able to show them all the perks of the Human Protein Atlas portal."

"There are so many important topics covered during these days, and I especially enjoyed the Monday late afternoon session where Robert Weinberg and Douglas Hanahan discussed the emerging hallmarks of cancer!"

Frida Henningson Johnson